Empirical Analysis on Price Policy Compensation Status in 4 Years after the Drug Zero Profit Policy
- VernacularTitle:药品零差价四年后物价政策补偿到位情况实证分析
- Author:
lei Chu ZHONG
1
;
he Qing SHOU
Author Information
- Keywords: drug zero profit; price policy; compensation
- From: Chinese Health Economics 2017;36(9):25-27
- CountryChina
- Language:Chinese
- Abstract: Objective:Retrospective analysis was conducted on the status of drug profit decreasing and pricing compensation profits increasing after the implementation of drug zero profit policy.The ratio of pricing policy compensation in place and the reform effects were evaluated to provide references for poliey making on implementing drug zero profit policy.Methods:The total usage of western medicine and Chinese patent medicine,the item of medical charging costs and item times before and after the implementation of drug zero profit,the decreasing of drug profits by outpatient and inpatient and the increasing of medical items were selected from hospital information system from 2013 to 2016.Results:From 2013 to 2016,the price of compensation policy in place rates were 94.59％,89.51％,95.18％,95.64％;4 year total compensation policy in place rate was 93.67％;outpatient compensation mainly by inspecting fee (75.22％),the cost of treatment (11.18％),surgery (5.91％);hospital compensation mainly surgical fees,nursing fees (36.40％)(19.09％),(19.08％) medical expenses and treatment expenses (13.53％);a good compensation effect of price policy.Conclusion:The compensation of price policy was in accordance with the expectation of reform,and the sharing of information with the competent department of price could help to establish a scientific and reasonable price compensation policy.It needed to further promote the reform of drug and comsumable usage control.
